by Ellen Goldbaum
Studies on Alzheimer's disease and other forms of dementia have long focused on what's happening inside the brain. Now an international research team studying Alzheimer's and mild cognitive impairment is reporting potentially significant findings on a vascular abnormality outside the brain.
The finding has potential implications for a better understanding of Alzheimer's and other neurological disorders associated with aging.
The pilot study was published in the Journal of Alzheimer's Disease Nov. 8 online ahead of print by researchers from the University at Buffalo, the University of Bradford in the United Kingdom and National Yang-Ming University School of Medicine in Taiwan. The authors caution that the study is small and that the results must be validated in larger, future studies.
They studied a hemodynamic abnormality in the internal jugular veins called jugular venous reflux or JVR. It occurs when the pressure gradient reverses the direction of blood flow in the veins, causing blood to leak backwards into the brain.
JVR occurs in certain physiological situations, if the internal jugular vein valves do not open and close properly, which occurs more frequently in the elderly. This reverse flow is also believed to impair cerebral venous drainage.
The brain's white matter is made of myelin and axons that enable communication between nerve cells.
"We were especially interested to find an association between JVR and white matter changes in the brains of patients with Alzheimer's disease and those with mild cognitive impairment," says Robert Zivadinov, MD, PhD, FAAN, professor of neurology at the UB School of Medicine and Biomedical Sciences and senior author.
"Age-related white matter changes have long been associated with dementia and faster cognitive decline," he says. "To the best of our knowledge, our study is the first to show that JVR is associated with a higher frequency of white matter changes, which occur in patients with mild cognitive impairment and Alzheimer's disease."
Ching-Ping Chung, the first author on the study and assistant professor of neurology at National Yang-Ming University, adds: "We are the first to observe that JVR may be associated with formation of these lesions in the brain, given the fact that Alzheimer's patients have more white matter lesions than healthy people.
"If this observation is validated in larger studies," she continues, "it could be significant for the development of new diagnostic tools and treatments for pathological white matter lesions developed in Alzheimer's disease and other forms of dementia."
White matter changes have been found to have a direct relationship to the buildup of amyloid plaque long seen as central to the development of Alzheimer's disease.
"The accumulation of amyloid plaque may result from the inability of cerebrospinal fluid to be properly cleared from the brain," says Clive Beggs, second author on the study and professor of medical engineering at the University of Bradford. In addition, he says, the study found that JVR appeared to be associated with dirty-appearing white matter, which is thought to represent early stage lesion formation.
"To the best of our knowledge, this is one of the first studies to explore the impact of dirty-appearing white matter in the elderly," Beggs continues. He adds that the significance of dirty-appearing white matter in the elderly needs more study.
The research involved 12 patients with Alzheimer's disease, 24 with mild cognitive impairment and 17 age-matched elderly controls. Participants underwent Doppler ultrasound exams and magnetic resonance imaging scans.
The impact of hemodynamic changes in veins from the brain to the neck has been the focus of numerous studies by Zivadinov and colleagues at UB and institutions worldwide.
"Given the major finding of our group in 2011 that both healthy controls and people with a variety of neurological diseases present with structural and hemodynamic changes of the extracranial venous system, we thought it was important to study how they might be involved in the development of Alzheimer's disease and other important neurodegenerative conditions," he explains.
Zivadinov notes that the frequency of JVR increases with aging and its accumulated effects on cerebral circulation may take many years to develop. Patients are likely to be asymptomatic for a long time, which would explain why the condition is seen in both healthy people and those with neurological diseases, he adds.
Explore further: It's not just amyloid: White matter hyperintensities and Alzheimer's disease
Medical Xpress on facebook
Related Stories
It's not just amyloid: White matter hyperintensities and Alzheimer's disease
Feb 19, 2013
(Medical Xpress)—New findings by Columbia researchers suggest that along with amyloid deposits, white matter hyperintensities (WMHs) may be a second necessary factor for the development of Alzheimer's disease.
In elderly, hardening of arteries linked to plaques in brain
Oct 16, 2013
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published ...
Brain circuitry loss may be a very early sign of cognitive decline in healthy elderly people
Sep 09, 2013
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory ...
Brain atrophy seen in patients with diabetes
Aug 23, 2013
(HealthDay)—Brain atrophy rather than cerebrovascular lesions may explain the relationship between type 2 diabetes mellitus (T2DM) and cognitive impairment, according to a study published online Aug. 12 ...
FDA approves GE brain imaging tool for Alzheimer's (Update)
Oct 25, 2013
The U.S. Food and Drug Administration on Friday approved a radioactive imaging chemical from General Electric to help screen patients for Alzheimer's disease and dementia.
Recommended for you
Pinpointing the connection between diet and dementia
Nov 22, 2013
Alzheimer's disease is a degenerative disorder affecting between 50 percent and 70 percent of all dementia sufferers. As neurons are killed slowly yet progressively, sufferers experience memory loss and confusion, ...
Poetry breaks through fog of Alzheimer's sufferers
Nov 22, 2013
The teenager's voice breaks the silence that hangs over the dozing, grey-haired figures. "If you can keep your head when all about you are losing theirs and blaming it on you," she recites—"you'll be a man, my son", finishes ...
Study reveals how variant forms of APOE protein impact risk of Alzheimer's disease
Nov 20, 2013
Carrying a particular version of the gene for apolipoprotein E (APOE) is the major known genetic risk factor for the sporadic, late-onset form of Alzheimer's disease, but exactly how that variant confers increased risk has ...
Trial set to determine Alzheimer's onset origins
Nov 19, 2013
A world-first clinical trial being conducted in WA is exploring whether testosterone and fish oil may prove to be the key in preventing or postponing Alzheimer's disease.
The benefits of a spotless mind
Nov 15, 2013
Alzheimer's disease is an age-related memory disorder characterized by the accumulation of clumps of the toxic amyloid-β (Aβ) protein fragment in the extracellular space around neurons in the brain. Drugs ...
Understanding a protein's role in familial Alzheimer's disease
Nov 14, 2013
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing ...
User comments
© Medical Xpress 2011-2013, Phys.org network
by Ellen Goldbaum
Studies on Alzheimer's disease and other forms of dementia have long focused on what's happening inside the brain. Now an international research team studying Alzheimer's and mild cognitive impairment is reporting potentially significant findings on a vascular abnormality outside the brain.
The finding has potential implications for a better understanding of Alzheimer's and other neurological disorders associated with aging.
The pilot study was published in the Journal of Alzheimer's Disease Nov. 8 online ahead of print by researchers from the University at Buffalo, the University of Bradford in the United Kingdom and National Yang-Ming University School of Medicine in Taiwan. The authors caution that the study is small and that the results must be validated in larger, future studies.
They studied a hemodynamic abnormality in the internal jugular veins called jugular venous reflux or JVR. It occurs when the pressure gradient reverses the direction of blood flow in the veins, causing blood to leak backwards into the brain.
JVR occurs in certain physiological situations, if the internal jugular vein valves do not open and close properly, which occurs more frequently in the elderly. This reverse flow is also believed to impair cerebral venous drainage.
The brain's white matter is made of myelin and axons that enable communication between nerve cells.
"We were especially interested to find an association between JVR and white matter changes in the brains of patients with Alzheimer's disease and those with mild cognitive impairment," says Robert Zivadinov, MD, PhD, FAAN, professor of neurology at the UB School of Medicine and Biomedical Sciences and senior author.
"Age-related white matter changes have long been associated with dementia and faster cognitive decline," he says. "To the best of our knowledge, our study is the first to show that JVR is associated with a higher frequency of white matter changes, which occur in patients with mild cognitive impairment and Alzheimer's disease."
Ching-Ping Chung, the first author on the study and assistant professor of neurology at National Yang-Ming University, adds: "We are the first to observe that JVR may be associated with formation of these lesions in the brain, given the fact that Alzheimer's patients have more white matter lesions than healthy people.
"If this observation is validated in larger studies," she continues, "it could be significant for the development of new diagnostic tools and treatments for pathological white matter lesions developed in Alzheimer's disease and other forms of dementia."
White matter changes have been found to have a direct relationship to the buildup of amyloid plaque long seen as central to the development of Alzheimer's disease.
"The accumulation of amyloid plaque may result from the inability of cerebrospinal fluid to be properly cleared from the brain," says Clive Beggs, second author on the study and professor of medical engineering at the University of Bradford. In addition, he says, the study found that JVR appeared to be associated with dirty-appearing white matter, which is thought to represent early stage lesion formation.
"To the best of our knowledge, this is one of the first studies to explore the impact of dirty-appearing white matter in the elderly," Beggs continues. He adds that the significance of dirty-appearing white matter in the elderly needs more study.
The research involved 12 patients with Alzheimer's disease, 24 with mild cognitive impairment and 17 age-matched elderly controls. Participants underwent Doppler ultrasound exams and magnetic resonance imaging scans.
The impact of hemodynamic changes in veins from the brain to the neck has been the focus of numerous studies by Zivadinov and colleagues at UB and institutions worldwide.
"Given the major finding of our group in 2011 that both healthy controls and people with a variety of neurological diseases present with structural and hemodynamic changes of the extracranial venous system, we thought it was important to study how they might be involved in the development of Alzheimer's disease and other important neurodegenerative conditions," he explains.
Zivadinov notes that the frequency of JVR increases with aging and its accumulated effects on cerebral circulation may take many years to develop. Patients are likely to be asymptomatic for a long time, which would explain why the condition is seen in both healthy people and those with neurological diseases, he adds.
Explore further: It's not just amyloid: White matter hyperintensities and Alzheimer's disease
Medical Xpress on facebook
Related Stories
It's not just amyloid: White matter hyperintensities and Alzheimer's disease
Feb 19, 2013
(Medical Xpress)—New findings by Columbia researchers suggest that along with amyloid deposits, white matter hyperintensities (WMHs) may be a second necessary factor for the development of Alzheimer's disease.
In elderly, hardening of arteries linked to plaques in brain
Oct 16, 2013
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published ...
Brain circuitry loss may be a very early sign of cognitive decline in healthy elderly people
Sep 09, 2013
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory ...
Brain atrophy seen in patients with diabetes
Aug 23, 2013
(HealthDay)—Brain atrophy rather than cerebrovascular lesions may explain the relationship between type 2 diabetes mellitus (T2DM) and cognitive impairment, according to a study published online Aug. 12 ...
FDA approves GE brain imaging tool for Alzheimer's (Update)
Oct 25, 2013
The U.S. Food and Drug Administration on Friday approved a radioactive imaging chemical from General Electric to help screen patients for Alzheimer's disease and dementia.
Recommended for you
Pinpointing the connection between diet and dementia
Nov 22, 2013
Alzheimer's disease is a degenerative disorder affecting between 50 percent and 70 percent of all dementia sufferers. As neurons are killed slowly yet progressively, sufferers experience memory loss and confusion, ...
Poetry breaks through fog of Alzheimer's sufferers
Nov 22, 2013
The teenager's voice breaks the silence that hangs over the dozing, grey-haired figures. "If you can keep your head when all about you are losing theirs and blaming it on you," she recites—"you'll be a man, my son", finishes ...
Study reveals how variant forms of APOE protein impact risk of Alzheimer's disease
Nov 20, 2013
Carrying a particular version of the gene for apolipoprotein E (APOE) is the major known genetic risk factor for the sporadic, late-onset form of Alzheimer's disease, but exactly how that variant confers increased risk has ...
Trial set to determine Alzheimer's onset origins
Nov 19, 2013
A world-first clinical trial being conducted in WA is exploring whether testosterone and fish oil may prove to be the key in preventing or postponing Alzheimer's disease.
The benefits of a spotless mind
Nov 15, 2013
Alzheimer's disease is an age-related memory disorder characterized by the accumulation of clumps of the toxic amyloid-β (Aβ) protein fragment in the extracellular space around neurons in the brain. Drugs ...
Understanding a protein's role in familial Alzheimer's disease
Nov 14, 2013
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment